Pack of 10 Vitamin Combustin Pharmaceutical Preparations GmbH Ingredients Active ingredient: 1 ml solution for injection contains1000 g cyanocobalamin
Compounded BPC-157 would be prepared by a licensed pharmacy under prescriber direction for a specific patient, an activity Health Canada has flagged as outside permissible scope for unauthorized injectable peptides in Canada (and one that was blocked in the United States during the Category 2 period from late 2023 to April 2026)
Typically, BPC 157 should be stored in a cool, dry place and kept out of direct sunlight
Vitamin B12 deficiency is often found in people that have digestive disorders such as Crohns disease or celiac disease, or have had gastrointestinal surgery in the past
As of July 2026, the BPC-157 evidence base consists entirely of preclinical data, plus one small IV safety pilot in two adults and one Phase 2 trial currently recruiting
Bottom Line BPC157 remains an experimental peptide with mechanistic plausibility derived from preclinical models but insufficient human data to claim clinical efficacy or long term safety, and its regulatory and anti doping status increase risk for patients and athletes considering unsupervised use
